Skip to content

Non-invasive Diagnostic for Assessing Elevated Intracranial Pressure

Non-invasive Diagnostic for Assessing Elevated Intracranial Pressure

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03418753
Enrollment
60
Registered
2018-02-01
Start date
2018-05-10
Completion date
2023-05-10
Last updated
2023-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial Pressure Increase

Keywords

noninvasive diagnosis

Brief summary

The study is a prospective, multi-center, non-randomized, open label observational study. The objective of this study is to compare the accuracy of the EyeBOX to a clinical diagnosis of abnormal ICP as determined by an external ventriculostomy drain (EVD) or ventriculostomy catheter.

Interventions

DIAGNOSTIC_TESTEyeBOX for ICP

non-invasive ICP Score algorithm using eye-tracking data from the EyeBOX(TM) device, which tracks the movement of the pupils over time

Sponsors

Oculogica, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
4 Years to 70 Years

Inclusion criteria

1. Provide written informed consent. 2. Require placement of an ICP monitor or ventriculostomy catheter for clinical purposes. 3. Be between the ages of 4 and 70 years old. 4. Have baseline vision correctable to within 20/500 bilaterally. 5. Have no prior history of ocular dysmotility. 6. Be awake with spontaneous eye opening at the time when eye tracking is performed.

Exclusion criteria

1. Have a prior history of strabismus, diplopia, or palsy of CN-III, IV or VI. 2. Be blind (no light perception), have missing eyes, be unable to open their eyes. 3. Have a prior history of ocular motility dysfunction. 4. Have had extensive prior eye surgery. 5. Have any physical or mental injury or baseline disability rendering task completion difficult. 6. Be intoxicated or have blood alcohol level greater than 0.2. 7. Be a prisoner or in the company of a police officer or law enforcement officer pending arrest.

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity and Specificityfrom time of enrollment through the period that ICP monitoring is required for clinical purposes up to 104 weeksEyeBOX assessment of abnormal ICP relative to invasive intracranial pressure monitor

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026